Matthew Feldman began his career as a biochemist, studying the molecular mechanisms of colon cancer progression in mouse models and human disease. He continued studying therapeutic strategies to mitigate RNA decay in classes of genetic disease. Leaving research to become an advocate for vaccine-preventable diseases, he began a career at the intersection of scientific innovation and digital communications. Speaking these two different languages, he became an effective champion of improving health through new solutions to critical challenges: first in the fight against childhood pneumonia and then in combating the global tuberculosis epidemic through the development of new, effective vaccines. Through cross-functional and international collaborations across therapeutic areas and industries, his work educated new audiences and sparked meaningful actions. In his current role as Marketing Director at ZyMōt Fertility (DxNow, Inc.), Matt thinks about the challenges facing reproductive medicine and the need for transformative innovations to reach people, to improve and create lives. Through his experiences as a scientist, communicator and as a patient, Matt is focused on how focusing on sperm health can help clinics, healthcare providers and patients in their fertility journey.